American healthcare services leader Owens & Minor, Inc. is trending towards a higher probability of bankruptcy. We advise continuous, thorough checkups of your portfolio when assessing public company financial risk.
Leveraging AI for accurate private company bankruptcy risk assessment, we were successful in predicting 70% of bankruptcies thus far in 2019 with the PAYCE® score.
CreditRiskMonitor currently estimates that financial losses stemming from U.S. public company bankruptcies alone will be in excess of $1.1 trillion, a greater figure than what was lost during the Great Recession.
The global economy appears to have deteriorated in a significant way during 2019 given the trends in negative yielding debt.
NantHealth, Inc. is experiencing some major distress. In this report, we diagnose their dangerous dealings in debt and what you can do as a creditor or a supplier to avoid risk.
When the FRISK® score becomes your go-to metric for financial risk analysis, incredibly accurate (read: good) adjustments follow.
It's unhealthy to think public company bankruptcy risk is a myth -- we show you why in this High Risk Report focusing on Quorum Health Corporation.
Two major U.S. pharmaceutical companies possess heightened bankruptcy risk largely due to lawsuits stemming from the opioid crisis. Our models are reflexive enough to give the most accurate forward-looking reads on financial risk when calamities strike.
Over the last two completed calendar years, CreditRiskMonitor's FRISK® score was able to predict U.S. public company bankruptcy at a near 98% rate of success.
As part of our look back at the year that was in 2018, the arrival of the PAYCE® score changed the way our subscribers monitored private company financial risk.
Chicago-based pharmaceutical leader Akorn, Inc. has seen its FRISK® score freefall down from a "9" to a "1" in a year's time.
Is Community Health Systems, Inc. on life support? Our High Risk Report offers a prognosis on this volatile American healthcare provider.